http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HR-P20090336-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2901e694724c2a759f619944cb7d2a4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-179
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
filingDate 2009-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bdebbd9e2c1644d46ce134495a0f095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48f77c94b2beeeb5d999a5bf153492f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_921871fe48886fee965baf33db9b600e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c45e6b8bb7dd54f6fa3ba1961891d01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ab20677a846458d0bab335f4568a8e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a8d75c4e66e01f3663f7b304512dc09
publicationDate 2009-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HR-P20090336-T1
titleOfInvention ANTI-TUMOR COMBINATIONS CONTAINING A VEGF AND 5-FU LOCK OR ONE OF ITS DERIVATIVES
abstract Combinations with a synergistic effect containing a VEGF trap and at least 5-fluorouracil or a 5-fluorouracil derivative, intended for use in the treatment of neoplastic diseases. The patent contains 6 more patent claims.
priorityDate 2004-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535626
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2092

Total number of triples: 33.